Table 3. Indicators of the incidence of stroke or systemic embolism during follow-up. Multivariate analysis.
| Variable | HR (95% CI) | p value |
|---|---|---|
| Left atrial enlargement (>45 mm) | 1.74 (1.25–2.42) | <0.01 |
| OAC prescription | 0.88 (0.63–1.24) | 0.46 |
| Heart failure | 1.30 (0.91–1.83) | 0.15 |
| Hypertension | 0.98 (0.70–1.37) | 0.88 |
| Age ≥ 75 years (vs. <65 years) | 2.26 (1.35–4.03) | <0.01 |
| Age 65–74 years (vs. <65 years) | 0.99 (0.55–1.86) | 0.97 |
| Diabetes mellitus | 1.01 (0.70–1.45) | 0.94 |
| History of stroke/SE | 1.55 (1.08–2.20) | 0.02 |
| Vascular disease | 1.10 (0.66–1.73) | 0.71 |
| Female sex | 0.93 (0.66–1.30) | 0.68 |
AF = atrial fibrillation, CI = confidence interval, HR = hazard ratio, OAC = oral anticoagulant, SE = systemic embolism.